Identification of Sorafenib as a Treatment for Type 1 Diabetes.
发布时间：2025-03-26
点击次数：
发表刊物：Front Immunol
合写作者：Yang Xiao
第一作者：Jianfeng Song, Qin Zeng
通讯作者：Zhiguang Zhou, Tuo Deng
是否译文：否
上一条： Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot
下一条： Chemokine CCL1 as a therapeutic target for pulmonary fibrosis: comments on 'The chemokine CCL1 triggers an AMFR？SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis'